Guangdong Marubi Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 873.796 million compared to CNY 793.720 million a year ago. Operating income was CNY 211.098 million compared to CNY 325.876 million a year ago. Net income was CNY 189.148 million compared to CNY 268.128 million a year ago. Basic earnings per share from continuing operations was CNY 0.47 compared to CNY 0.67 a year ago.